Toll Free: 1-888-928-9744

Human Milk Oligosaccharides Market Size, Share & Trends Analysis Report By Application (Infant Formula, Functional Food & Beverages, Food Supplements), Region (North America, Europe, Asia Pacific), And Segment Forecasts, 2019 - 2025

Published: Nov, 2019 | Pages: 120 | Publisher: Grand View Research
Industry: Personal Care | Report Format: Electronic (PDF)

The global human milk oligosaccharides market size is expected to reach USD 71.2 million by 2025, according to a new report by Grand View Research, Inc. The human milk oligosaccharides (HMO) market is projected to witness a strong CAGR of 21.8% during the forecast period. Increasing awareness regarding HMO and better understanding regarding its functions is expected to fuel its demand over the forecast period.

Moreover, changing consumer lifestyles and their increasing concerns regarding health and wellness are expected to augment market growth. HMOs in functional food & beverage products and food supplements can help in treatment of certain disorders and high risk conditions, thus boosting the product demand. However, high costs associated with the product may challenge market growth over the forecasts period.

HMO is a major source of sialic acid, which is an important part of the plasma membrane of nerve cells. Over 150 structurally diverse HMOs are available in nature. Moreover, scientists have been trying to develop various structures of HMOs synthetically, for use in the food industry – most particularly infant formulas and medical nutrition. These synthetically developed HMOs are safe for consumption by infants who cannot be breastfed, as well as children and adults.

HMOs are used in various applications including infant formula, functional food & beverages, and food supplements, among others. Increasing health awareness and increasing consumption of infant formula are likely to boost the growth of the HMO market over the forecast period. In 1990, the infant mortality rate of infants was 63 deaths per 1,000 live births, and in 2017, which declined to the rate declined to only 29 deaths per 1,000 live births in 2017.

Infant formula is the largest and fastest-growing application segment of HMOs. High infant mortality rate and rising concerns regarding health and safety are factors likely to boost the market growth over the forecast period. HMOs play a key role in the proper development of infants. They are responsible for proper enhancement of brain, fighting certain harmful infections, and the development of the human gut.

HMOs are also being increasingly utilized in pharmaceutical applications. Furthermore, the prebiotic effects of HMOs make them suitable for use in functional foods & beverages and food supplements. Functional foods & beverages is the second-largest application segment of HMOs.

Further key findings from the report suggest:

• In terms of application, the infant formula segment is expected to grow at a CAGR of 21.9% over the forecast period

• Challenges associated in breast-feeding, such as personal comfort, time, diet, and frequency of feedings have led the increase in the consumption of infant formula.

• Incorporation of HMOs in functional food & beverages promote the growth of good bacteria and eliminates harmful bacteria including salmonella, listeria, and campylobacter

• The growing consumption of functional foods & beverages for improving gut health and overall immunity is expected to have significant impacts on the demand for HMOs over the forecast period

• Distribution agreements, capacity expansion, and investments for the development of low-cost technologies are among the major strategies adopted by major players to establish strong competitive positions in the human milk oligosaccharides market
 Table of Contents

Chapter 1 Methodology and Scope
                   1.1 Information Procurement
                        1.1.1 Purchased Database
                        1.1.2 Gvr’s Internal Database
                        1.1.3 Secondary Sources
                        1.1.4 Third Party Perspective
                        1.1.5 Primary Research
                   1.2 Information Analysis & Data Analysis Models
                   1.3 List to Data Sources
Chapter 2 Executive Summary
                   2.1 Market Snapshot
                   2.2 Segmental Insights
                   2.3 Competitive Insights
Chapter 3 Human Milk Oligosaccharides Market Variables, Trends & Scope
                   3.1 Market Lineage Outlook
                        3.1.1 Parent Market Outlook
                        3.1.2 Related Market Outlook
                   3.2 Penetration & Growth Prospect Mapping
                   3.3 Value chain analysis
                        3.3.1 Raw Material Trends
                             3.3.1.1 Major Raw Material Analysis
                             3.3.1.2 Procurement Best Practices
                   3.4 Sales Channel Analysis
                        3.4.1 Vendor Selection Criteria
                   3.5 Technology Overview
                        3.5.1 Technology Timeline
                   3.6 Regulatory Framework
                   3.7 Market Dynamics
                        3.7.1 Market Driver Analysis
                             3.7.1.1 Positive Dairy Industry Outlook
                             3.7.1.2 Growing Dietary Supplements Market
                             3.7.1.3. Growing Dietary Supplements Market
                        3.7.2 Market Restraint Analysis
                             3.7.2.1 High Production And R&D Cost
                   3.8 Business Environment Analysis
                        3.8.1 Porter’s Analysis
                             3.8.1.1 Threat of new entrants
                             3.8.1.2 Bargaining power of suppliers
                             3.8.1.3 Bargaining power of buyers
                             3.8.1.4 Threat of substitutes
                             3.8.1.5 Competitive rivalry
                        3.8.2 PESTLE Analysis
                             3.8.2.1 Political Landscape
                             3.8.2.2 Environmental Landscape
                             3.8.2.3 Social Landscape
                             3.8.2.4 Technology Landscape
                             3.8.2.5 Economic Landscape
                             3.8.2.6 Legal Landscape
                        3.8.3 Major Deals & Strategic Alliances Analysis
                             3.8.3.1 Mergers & Acquisitions
                             3.8.3.2 Licensing & partnership
                   3.9 Market Entry Strategy
Chapter 4 Human Milk Oligosaccharides Market: Product Estimates & Trend Analysis
                   4.1 2’-Fucosyllactose (2’FL)
                        4.1.1 Specifications
                        4.1.2 Key Suppliers
                        4.1.3 Applications
                        4.1.4 Patents
                        4.1.5 Production Routes
                        4.1.6 Manufacturers
                   4.2 3’-Fucosyllactose (3’FL)
                        4.2.1 Specifications
                        4.2.2 Key Suppliers
                        4.2.3 Applications
                        4.2.4 Patents
                        4.2.5 Production Routes
                        4.2.6 Manufacturers
                   4.3 3’-Sialyllactose (3’SL)
                        4.3.1 Specifications
                        4.3.2 Key Suppliers
                        4.3.3 Applications
                        4.3.4 Patents
                        4.3.5 Production Routes
                        4.3.6 Manufacturers
                   4.4 6’-Sialyllactose (6’SL)
                        4.4.1 Specifications
                        4.4.2 Key Suppliers
                        4.4.3 Applications
                        4.4.4 Patents
                        4.4.5 Production Routes
                        4.4.6 Manufacturers
                   4.5 Lacto-N-tetraose (LNT)
                        4.5.1 Specifications
                        4.5.2 Key Suppliers
                        4.5.3 Patents
                        4.5.4 Applications
                        4.5.5 Production Routes
                        4.5.6 Manufacturers
                   4.6 Lacto-N-neotetraose (LNnT)
                        4.6.1 Specifications
                        4.6.2 Key Suppliers
                        4.6.3 Patents
                        4.6.4 Applications
                        4.6.5 Production Routes
                        4.6.6 Manufacturers
Chapter 5 Human Milk Oligosaccharides Market: Application Estimates & Trend Analysis
                   5.1 Definitions & Scope
                   5.2 Application Movement & Market Share Analysis, 2018 & 2025
                   5.3 Infant Formula
                        5.3.1 Global HMO Market Estimates And Forecast In Infant Formula, 2014 - 2025 (Tons) (Usd ‘000)
                        5.3.2 Global HMO Market Estimates And Forecast In Infant Formula, By Region, 2014 - 2025 (Tons) (Usd ‘000)
                   5.4 Functional Food & Beverages
                        5.4.1 Global HMO Market Estimates And Forecast In Functional Food & Beverages, 2014 - 2025 (Tons) (Usd ‘000)
                        5.4.2 Global HMO Market Estimates And Forecast In Functional Food & Beverages, By Region, 2014 - 2025 (Tons) (Usd ‘000)
                   5.5 Food Supplements
                        5.5.1 Global HMO Market Estimates And Forecast In Food Supplements, 2014 - 2025 (Tons) (Usd ‘000)
                        5.5.2 Global HMO Market Estimates And Forecast In Food Supplements, By Region, 2014 - 2025 (Tons) (Usd ‘000)
                   5.6 Others
                        5.6.1 Global HMO Market Estimates And Forecast In Others, 2014 - 2025 (Tons) (Usd ‘000)
                        5.6.2 Global HMO Market Estimates And Forecast In Others, By Region, 2014 - 2025 (Tons) (Usd ‘000)
Chapter 6 Human Milk Oligosaccharides Market: Regional Estimates & Trend Analysis
                   6.1 Definitions & Scope
                   6.2 Regional movement & market share analysis, 2018 & 2025
                   6.3. North America
                        6.3.1 North America HMO Market Estimates And Forecasts, 2014 - 2025 (Tons) (Usd ‘000)
                        6.3.2 North America HMO Market Estimates And Forecasts, By Application, 2014 - 2025 (Tons) (Usd ‘000)
                        6.3.4 U.S.
                             6.3.4.1 U.S HMO market estimates and forecasts, 2014 - 2025 (Tons) (USD ‘000)
                             6.3.4.2 U.S HMO market estimates and forecasts, by application, 2014 - 2025 (Tons) (USD ‘000)
                        6.3.5 Canada
                             6.3.5.1 Canada HMO market estimates and forecasts, 2014 - 2025 (Tons) (USD ‘000)
                             6.3.5.2 Canada HMO market estimates and forecasts, by application, 2014 - 2025 (Tons) (USD ‘000)
                        6.3.6 Mexico
                             6.3.6.1 Mexico HMO Market Estimates And Forecasts, 2014 - 2025 (Tons) (Usd ‘000)
                             6.3.6.2 Mexico HMO Market Estimates And Forecasts, By Application, 2014 - 2025 (Tons) (Usd ‘000)
                   6.4 Europe
                        6.4.1 Europe HMO Market Estimates And Forecasts, 2014 - 2025 (Tons) (Usd ‘000)
                        6.4.2 Europe HMO Market Estimates And Forecasts, By Application, 2014 - 2025 (Tons) (Usd ‘000)
                        6.4.3 Germany
                             6.4.3.1 Germany HMO market estimates and forecasts, 2014 - 2025 (Tons) (USD ‘000)
                             6.4.3.2 Germany HMO market estimates and forecasts, by application, 2014 - 2025 (Tons) (USD ‘000)
                        6.4.4 UK
                             6.4.4.1 UK HMO market estimates and forecasts, 2014 - 2025 (Tons) (USD ‘000)
                             6.4.4.2 UK HMO market estimates and forecasts, by application, 2014 - 2025 (Tons) (USD ‘000)
                        6.4.5 France
                             6.4.5.1 France HMO market estimates and forecasts, 2014 - 2025 (Tons) (USD ‘000)
                             6.4.5.2 France HMO market estimates and forecasts, by application, 2014 - 2025 (Tons) (USD ‘000)
                   6.5 Asia Pacific
                        6.5.1 Asia Pacific HMO Market Estimates And Forecasts, 2014 - 2025 (Tons) (Usd ‘000)
                        6.5.2 Asia Pacific HMO Market Estimates And Forecasts, By Application, 2014 - 2025 (Tons) (Usd ‘000)
                        6.5.3 China
                             6.5.3.1 China HMO market estimates and forecasts, 2014 - 2025 (Tons) (USD ‘000)
                             6.5.3.2 China HMO market estimates and forecasts, by application, 2014 - 2025 (Tons) (USD ‘000)
                        6.5.4 India
                             6.5.4.1 India HMO market estimates and forecasts, 2014 - 2025 (Tons) (USD ‘000)
                             6.5.4.2 India HMO market estimates and forecasts, by application, 2014 - 2025 (Tons) (USD ‘000)
                        6.5.5 Japan
                             6.5.5.1 Japan HMO market estimates and forecasts, 2014 - 2025 (Tons) (USD ‘000)
                             6.5.5.2 Japan HMO market estimates and forecasts, by application, 2014 - 2025 (Tons) (USD ‘000)
                        6.5.6 Australia
                             6.5.6.1 Australia HMO market estimates and forecasts, 2014 - 2025 (Tons) (USD ‘000)
                             6.5.6.2 Australia HMO market estimates and forecasts, by application, 2014 - 2025 (Tons) (USD ‘000)
                   6.6. Central & South America
                        6.6.1 Central & South America HMO Market Estimates And Forecasts, 2014 - 2025 (Tons) (Usd ‘000)
                        6.6.2 Central & South America HMO Market Estimates And Forecasts, By Application, 2014 - 2025 (Tons) (Usd ‘000)
                        6.6.3 Brazil
                             6.6.3.1 Brazil HMO market estimates and forecasts, 2014 - 2025 (Tons) (USD ‘000)
                             6.6.3.2 Brazil HMO market estimates and forecasts, by application, 2014 - 2025 (Tons) (USD ‘000)
                   6.7 Middle East & Africa
                        6.7.1 Middle East & Africa HMO Market Estimates And Forecasts, 2014 - 2025 (Tons) (Usd ‘000)
                        6.7.2 Middle East & Africa HMO Market Estimates And Forecasts, By Application, 2014 - 2025 (Tons) (Usd ‘000)
                        6.7.3 UAE
                             6.7.3.1 UAE HMO market estimates and forecasts, 2014 - 2025 (Tons) (USD ‘000)
                             6.7.3.2 UAE HMO market estimates and forecasts, by application, 2014 - 2025 (Tons) (USD ‘000)
Chapter 7 Competitive Analysis
                   7.1 Key Players’ Recent Developments & Their Impact
                   7.2 Key Innovators, Market Leader, and Emerging Players
                   7.3 Vendor Landscape
                        7.3.1 List Of Key Distributors & Channel Partners
                        7.3.2 Key Customers
                   7.4 Public Companies
                        7.4.1 Company Market Position Analysis
                        7.4.2 Company Ranking
                        7.4.3 Competitive Dashboard Analysis
                        7.4.4 Market Differentiators
                        7.4.5 Synergy Analysis: Major Deals & Strategic Alliances
                        7.4.6 SWOT Analysis Of Public Companies
                   7.5 Private Companies
                        7.5.1 List Of Key Emerging Companies/Technology Disruptors/Innovators
                        7.5.2 Geographical Presence
                   7.6 Company market position analysis
Chapter 8 Company Profiles
                   8.1 Inbiose NV
                        8.1.1 Company Overview
                        8.1.2 Financial Performance
                        8.1.3 Product Benchmarking
                        8.1.4 Strategic Initiatives
                   8.2 Elicityl S.A.
                        8.2.1 Company Overview
                        8.2.2 Product Benchmarking
                        8.2.3 Strategic Initiatives
                   8.3 Jennewein Biotechnologie GmbH
                        8.3.1 Company Overview
                        8.3.2 Product Benchmarking
                        8.3.3 Strategic Initiatives
                   8.4 Glycom A/S
                        8.4.1 Company Overview
                        8.4.2 Product Benchmarking
                        8.4.3 Strategic Initiatives
                   8.5 Medolac Laboratories
                        8.5.1 Company Overview
                        8.5.2 Product Benchmarking
                        8.5.3 Strategic Initiatives
                   8.6 ZuChem Inc.
                        8.6.1 Company Overview
                        8.6.2 Product Benchmarking
                        8.6.3 Strategic Initiatives
                   8.7 Glycosyn LLC
                        8.7.1 Company Overview
                        8.7.2 Product Benchmarking
                        8.7.3 Strategic Initiatives
List of Tables

Table 1 Human milk oligosaccharides (HMO) market- Driver analysis
Table 2 Human milk oligosaccharides (HMO) market- Restraint analysis
Table 3 2’FL Specifications
Table 4 2’FL Key Suppliers
Table 5 2’FL Patents
Table 6 3’FL Specifications
Table 7 3’FL Key Suppliers
Table 8 3’FL Patents
Table 9 3’-Sialyllactose (3’SL) Specifications
Table 10 3’-Sialyllactose (3’SL) Suppliers
Table 11 3’-Sialyllactose (3’SL) Patents
Table 12 6’SL Specifications
Table 13 6’SL Key Suppliers
Table 14 6’SL Patents
Table 15 LNT - Specifications
Table 16 LNT Suppliers
Table 17 LNT Patents
Table 18 LNnT - Specifications
Table 19 LNnT Suppliers
Table 20 LNnT Patents
Table 21 Global HMO market estimates and forecast in infant formula, 2014 - 2025 (Tons) (USD ‘000)
Table 22 Global HMO market estimates and forecast in infant formula, by region, 2014 - 2025 (Tons)
Table 23 Global HMO market estimates and forecast in infant formula, by region, 2014 - 2025 (USD’000)
Table 24 Global HMO market estimates and forecast in functional food & beverages, 2014 - 2025 (Tons) (USD ‘000)
Table 25 Global HMO market estimates and forecast in functional food & beverages, by region, 2014 - 2025 (Tons)
Table 26 Global HMO market estimates and forecast in functional food & beverages, by region, 2014 - 2025 (USD’000)
Table 27 Global HMO market estimates and forecast in food supplements, 2014 - 2025 (Tons) (USD ‘000)
Table 28 Global HMO market estimates and forecast in food supplements, by region, 2014 - 2025 (Tons)
Table 29 Global HMO market estimates and forecast in food supplement, by region, 2014 - 2025 (USD’000)
Table 30 Global HMO market estimates and forecast in others, 2014 - 2025 (Tons) (USD ‘000)
Table 31 Global HMO market estimates and forecast in others, by region, 2014 - 2025 (Tons)
Table 32 Global HMO market estimates and forecast in others, by region, 2014 - 2025 (USD’000)
Table 33 North America HMO market estimates and forecasts, 2014 - 2025 (Tons) (USD ‘000)
Table 34 North America HMO market estimates and forecasts, by application, 2014 - 2025 (Tons)
Table 35 North America HMO market estimates and forecasts, by application, 2014 - 2025 (USD’ 000)
Table 36 U.S HMO market estimates and forecasts, 2014 - 2025 (Tons) (USD ‘000)
Table 37 U.S HMO market estimates and forecasts, by application, 2014 - 2025 (Tons)
Table 38 U.S HMO market estimates and forecasts, by application, 2014 - 2025 (USD’000)
Table 39 Canada HMO market estimates and forecasts, 2014 - 2025 (Tons) (USD ‘000)
Table 40 Canada HMO market estimates and forecasts, by application, 2014 - 2025 (Tons)
Table 41 Canada HMO market estimates and forecasts, by application, 2014 - 2025 (USD’000)
Table 42 Mexico HMO market estimates and forecasts, 2014 - 2025 (Tons) (USD ‘000)
Table 43 Mexico HMO market estimates and forecasts, by application, 2014 - 2025 (Tons)
Table 44 Mexico HMO market estimates and forecasts, by application, 2014 - 2025 (USD’000)
Table 45 Europe HMO market estimates and forecasts, 2014 - 2025 (Tons) (USD ‘000)
Table 46 Europe HMO market estimates and forecasts, by application, 2014 - 2025 (Tons)
Table 47 Europe HMO market estimates and forecasts, by application, 2014 - 2025 (USD’000)
Table 48 UK HMO market estimates and forecasts, 2014 - 2025 (Tons) (USD ‘000)
Table 49 UK HMO market estimates and forecasts, by application, 2014 - 2025 (Tons)
Table 50 UK HMO market estimates and forecasts, by application, 2014 - 2025 (USD’000)
Table 51 Germany HMO market estimates and forecasts, 2014 - 2025 (Tons) (USD ‘000)
Table 52 Germany HMO market estimates and forecasts, by application, 2014 - 2025 (Tons)
Table 53 Germany HMO market estimates and forecasts, by application, 2014 - 2025 (USD’000)
Table 54 France HMO market estimates and forecasts, 2014 - 2025 (Tons) (USD ‘000)
Table 55 France HMO market estimates and forecasts, by application, 2014 - 2025 (Tons)
Table 56 France HMO market estimates and forecasts, by application, 2014 - 2025 (USD’000)
Table 57 Asia Pacific HMO market estimates and forecasts, 2014 - 2025 (Tons) (USD ‘000)
Table 58 Asia Pacific HMO market estimates and forecasts, by application, 2014 - 2025 (Tons)
Table 59 Asia Pacific HMO market estimates and forecasts, by application, 2014 - 2025 (USD ‘000)
Table 60 China HMO market estimates and forecasts, 2014 - 2025 (Tons) (USD ‘000)
Table 61 China HMO market estimates and forecasts, by application, 2014 - 2025 (Tons)
Table 62 China HMO market estimates and forecasts, by application, 2014 - 2025 (USD ‘000)
Table 63 Japan HMO market estimates and forecasts, 2014 - 2025 (Tons) (USD ‘000)
Table 64 Japan HMO market estimates and forecasts, by application, 2014 - 2025 (Tons)
Table 65 Japan HMO market estimates and forecasts, by application, 2014 - 2025 (USD ‘000)
Table 66 India HMO market estimates and forecasts, 2014 - 2025 (Tons) (USD ‘000)
Table 67 India HMO market estimates and forecasts, by application, 2014 - 2025 (Tons)
Table 68 India HMO market estimates and forecasts, by application, 2014 - 2025 (USD ‘000)
Table 69 Australia HMO market estimates and forecasts, 2014 - 2025 (Tons) (USD ‘000)
Table 70 Australia HMO market estimates and forecasts, by application, 2014 - 2025 (Tons)
Table 71 Australia HMO market estimates and forecasts, by application, 2014 - 2025 (USD ‘000)
Table 72 Central & South America HMO market estimates and forecasts, 2014 - 2025 (Tons) (USD ‘000)
Table 73 Central & South America HMO market estimates and forecasts, by application, 2014 - 2025 (Tons)
Table 74 Central & South America HMO market estimates and forecasts, by application, 2014 - 2025 (USD ‘000)
Table 75 Brazil HMO market estimates and forecasts, 2014 - 2025 (Tons) (USD ‘000)
Table 76 Brazil HMO market estimates and forecasts, by application, 2014 - 2025 (Tons)
Table 77 Brazil HMO market estimates and forecasts, by application, 2014 - 2025 (USD ‘000)
Table 78 MEA HMO market estimates and forecasts, 2014 - 2025 (Tons) (USD ‘000)
Table 79 MEA HMO market estimates and forecasts, by application, 2014 - 2025 (Tons)
Table 80 MEA HMO market estimates and forecasts, by application, 2014 - 2025 (USD ‘000)
Table 81 UAE HMO market estimates and forecasts, 2014 - 2025 (Tons) (USD ‘000)
Table 82 UAE HMO market estimates and forecasts, by application, 2014 - 2025 (Tons)
Table 83 UAE HMO market estimates and forecasts, by application, 2014 - 2025 (USD ‘000)

List of Figures

Fig. 1 Information procurement
Fig. 2 Primary research pattern
Fig. 3 Primary research process
Fig. 4 Primary research approaches
Fig. 5 Human milk oligosaccharides (HMO) market snapshot, 2018 (USD’ 000)
Fig. 6 Human milk oligosaccharides (HMO) market segmentation
Fig. 7 Human milk oligosaccharides (HMO) market volume and revenue estimates and forecast, 2014 - 2025 (USD Thousand)(Tons)
Fig. 8 Value chain analysis
Fig. 9 Raw material outlook
Fig. 10 Market dynamics
Fig. 11 Global trade in dairy products, 2016 and 2017 (Thousand Tons)
Fig. 12 Global dietary supplements market, 2016-2024, (USD Million)
Fig. 13 Human milk oligosaccharides - Key opportunities prioritized
Fig. 14 Human milk oligosaccharides - Strategy framework
Fig. 5 Human milk oligosaccharides - Porter’s analysis
Fig. 6 Human milk oligosaccharides - PESTEL analysis
Fig. 15 Human milk oligosaccharides market share, by application , 2018 & 2025
Fig. 16 Human milk oligosaccharides market share, by region , 2018 & 2025 



To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $5950
Multi User - US $6950
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify